Phase 1 β Early testing in a small group of people (usually 20β80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(19 sites)
India
Sir Sayajirao General Hospital (SSG), Vadodara, Gujarat National Cancer Institute , All India Institute of Medical Sciences, Jhajjar, Haryana Health Care Global Enterprises, Bangalore, Karnataka Srinivasam Cancer Care Multi Speciality Hospitals India Pvt Ltd. , Bangalore 560072., Bangalore, Karnataka Jeevan Amrut Hematology Center, Aurangabad, Aurangabad, Maharashtra HCG Cancer Centre, Nagpur, Maharashtra Sahyadri Hospital Private Limited, Pune, Maharashtra Novo Solitaire Care, Pune, Maharashtra Armed Forces Medical College, Pune, Maharashtra Onco Life Cancer, Centre, Satara, Satara, Maharashtra Sunact Cancer Institute Pvt. Ltd, Thane, Maharashtra Siddharth Gupta Memorial Hospital,, Wardha, Maharashtra Tata Memorial Hospital, PΔrel, Mumbai AIIMS, New Delhi, New Delhi, New Delhi Max Super Specialty Hospital, Saket, New Delhi AIIMS, Bhubaneswar, Bhubaneswar, Odisha Somani Hospital, Jaipur, Rajasthan AIIMS, Rishikesh, Rishikesh, Uttarakhand Tata Medical Centre, Kolkata, West Bengal